日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Restoring adenosine balance in axial spondyloarthritis: a stage-specific framework for immune and structural modulation

恢复中轴型脊柱关节炎中的腺苷平衡:免疫和结构调节的阶段特异性框架

Tavasolian, Fataneh; Ravarian, Behdad; Lim, Melissa; Inman, Robert D

Regulatory T cells in axial spondyloarthritis

中轴型脊柱关节炎中的调节性T细胞

Pacheco, Addison; Tavasolian, Fataneh; Lim, Melissa; Inman, Robert D

Certolizumab Pegol Reduced Anterior Uveitis Flares Compared With Standard Non-Biologic Treatment: Results From an Overlap Weighting Analysis in High-Risk Patients With Axial Spondyloarthritis

与标准非生物制剂治疗相比,Certolizumab Pegol 可减少前葡萄膜炎发作:一项针对高危轴性脊柱关节炎患者的重叠加权分析结果

Haroon, Nigil; Baskurt, Zeynep; Chim, Tina; Inman, Robert D; Kumke, Thomas; Tham, Rachel; Kim, Mindy; van der Horst-Bruinsma, Irene; Gensler, Lianne S

Achieving inactive disease state in men and women with axial spondyloarthritis: results from a multi-country prospective observational study

一项多国前瞻性观察研究的结果显示,中轴型脊柱关节炎患者(包括男性和女性)如何达到疾病非活动状态

Poddubnyy, Denis; Sieper, Joachim; Akar, Servet; Muñoz-Fernández, Santiago; Haibel, Hildrun; Protopopov, Mikhail; Altmaier, Elisabeth; Ganz, Fabiana; Inman, Robert D

Impact of disease manifestations on first biologic drug survival in axial spondyloarthritis: a real-life Canadian study

疾病表现对中轴型脊柱关节炎患者首次生物制剂生存率的影响:一项加拿大真实世界研究

Hurtubise, Raphaël; Rohekar, Sherry; Haroon, Nigil; Baskurt, Zeynep; Chim, Tina; Zummer, Michel; Inman, Robert D; Richard, Nicolas

Radiographic Progression in Sacroiliac Joints in Patients With Axial Spondyloarthritis: Results From a Five-Year International Observational Study

轴性脊柱关节炎患者骶髂关节放射学进展:一项为期五年的国际观察性研究的结果

Poddubnyy, Denis; Sieper, Joachim; Akar, Servet; Muñoz-Fernández, Santiago; Haibel, Hildrun; Diekhoff, Torsten; Protopopov, Mikhail; Altmaier, Elisabeth; Ganz, Fabiana; Inman, Robert D

Canadian Patients With Axial Spondyloarthritis Require Almost a Decade To Be Diagnosed Leading to Severe Functional Limitation. Results From the International Map of Axial Spondyloarthritis (IMAS)

加拿大中轴型脊柱关节炎患者平均需要近十年才能确诊,导致严重的活动功能障碍。以上数据来自国际中轴型脊柱关节炎地图(IMAS)。

Rahman, Proton; Garrido-Cumbrera, Marco; Rohekar, Sherry; Mallinson, Michael G; Karam, Elie; Jovaisas, Algis V; Haroon, Nigil; Beach, Jeff; de Brum-Fernandes, Artur J; Cohen, Martin; Chan, Jonathan; Correa-Fernández, Jose; Leclerc, Patrick; Inman, Robert D

Biology and therapeutic potential of mesenchymal stem cell extracellular vesicles in axial spondyloarthritis

间充质干细胞细胞外囊泡在中轴型脊柱关节炎中的生物学特性和治疗潜力

Tavasolian, Fataneh; Inman, Robert D

Sustained low functional impairment in axial spondyloarthritis (axSpA): which are the primary outcomes that should be targeted to achieve this?

持续性低功能障碍在轴性脊柱关节炎(axSpA)中的发生:为实现这一目标,应重点关注哪些主要结果?

Maksymowych, Walter P; Inman, Robert D; Bessette, Louis; Rahman, Proton; Rampakakis, Emmanouil; Asin-Milan, Odalis; Rachich, Meagan; Marrache, Anne Marilise; Lehman, Allen J

Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III study

乌帕替尼治疗对生物制剂治疗无效的强直性脊柱炎患者的疗效和安全性:一项 III 期研究开放标签扩展研究的 1 年结果

Baraliakos, Xenofon; van der Heijde, Désirée; Sieper, Joachim; Inman, Robert D; Kameda, Hideto; Li, Yihan; Bu, Xianwei; Shmagel, Anna; Wung, Peter; Song, In-Ho; Deodhar, Atul